Citations

Citations to this article as recorded by  

• Highly Sensitive Detection of PIK3CA Mutations by Looping-Out Probes-Based Melting Curve Analysis
  Boheng Xu, Yanping Lan, Danjiao Luo, Yangsi Zheng, Runfang Ni, Guoqiang Su, Qiuying Huang, Qingge Li
  Biochemical Genetics.2024; 62(1): 77.     CrossRef
• Potential biomarkers in breast cancer drug development: application of the biomarker qualification evidentiary framework
  Eric Wang, Mackenzie Henderson, Priyanka Yalamanchili, Jenilee Cueto, Zahidul Islam, Charles Dharmani, Maribel Salas
  Biomarkers in Medicine.2024; 18(6): 265.     CrossRef
• Analysis of PIK3CA mutations in the primary and recurrent tumors of hormone receptor positive/human epidermal growth factor receptor 2 negative breast cancer
  Yue Wang, Xin Li, Shuang Zhang, Li Liang, Ling Xu, Yinhua Liu, Ting Li
  Japanese Journal of Clinical Oncology.2024; 54(9): 1024.     CrossRef
• Analysis of PIK3CA Mutation Concordance and Frequency in Primary and Different Distant Metastatic Sites in Breast Cancer
  Jieun Park, Soo Youn Cho, Eun Sol Chang, Minjung Sung, Ji-Young Song, Kyungsoo Jung, Sung-Su Kim, Young Kee Shin, Yoon-La Choi
  Cancer Research and Treatment.2023; 55(1): 145.     CrossRef
• Computational pathology to improve biomarker testing in breast cancer: how close are we?
  Elham Sajjadi, Chiara Frascarelli, Konstantinos Venetis, Giuseppina Bonizzi, Mariia Ivanova, Gianluca Vago, Elena Guerini-Rocco, Nicola Fusco
  European Journal of Cancer Prevention.2023; 32(5): 460.     CrossRef
• Clinicopathologic and Genomic Features in Triple-Negative Breast Cancer Between Special and No-Special Morphologic Pattern
  Ying-Zi Li, Bo Chen, Xiao-Yi Lin, Guo-Chun Zhang, Jian-Guo Lai, Cheukfai Li, Jia-Li Lin, Li-Ping Guo, Wei-Kai Xiao, Hsiaopei Mok, Chong-Yang Ren, Ling-Zhu Wen, Fang-Rong Cao, Xin Lin, Xiao-Fang Qi, Yang Liu, Ning Liao
  Frontiers in Oncology.2022;[Epub]     CrossRef
• PIK3CA Mutation as Potential Poor Prognostic Marker in Asian Female Breast Cancer Patients Who Received Adjuvant Chemotherapy
  Yoon Ah Cho, Seung Yeon Ko, Yong Joon Suh, Sanghwa Kim, Jung Ho Park, Hye-Rim Park, Jinwon Seo, Hyo Geun Choi, Ho Suk Kang, Hyun Lim, Ha Young Park, Mi Jung Kwon
  Current Oncology.2022; 29(5): 2895.     CrossRef
• Using an Improved Residual Network to Identify PIK3CA Mutation Status in Breast Cancer on Ultrasound Image
  Wen-Qian Shen, Yanhui Guo, Wan-Er Ru, Cheukfai Li, Guo-Chun Zhang, Ning Liao, Guo-Qing Du
  Frontiers in Oncology.2022;[Epub]     CrossRef
• Expert consensus on the clinical application of PI3K/AKT/mTOR inhibitors in the treatment of advanced breast cancer
  
  Cancer Innovation.2022; 1(1): 25.     CrossRef
• Clinicopathological characteristics and prognostic analysis of PIK3CA mutation in breast cancer patients in Northwest China
  Wei Lv, Chong Du, Yinbing Zhang, Fei Wu, Yaofeng Jin, Xi Chen, Xuan Liu, Cong Feng, Xingcong Ma, Shuqun Zhang
  Pathology - Research and Practice.2022; 238: 154063.     CrossRef
• Comparison of PIK3CA Mutation Prevalence in Breast Cancer Across Predicted Ancestry Populations
  Jessica W. Chen, Karthikeyan Murugesan, Justin Y. Newberg, Ethan S. Sokol, Heidi M. Savage, Thomas J. Stout, Sophia L. Maund, Katherine E. Hutchinson
  JCO Precision Oncology.2022;[Epub]     CrossRef
• PIK3CA-mutated breast cancer: from research to clinical practice
  A. L. Kornietskaya, L. V. Bolotina, S. F. Evdokimova, V. V. Savchina, Yu. B. Karagodina, A. A. Kachmazov
  Meditsinskiy sovet = Medical Council.2022; (22): 148.     CrossRef
• The Correlation of Mutations and Expressions of Genes within the PI3K/Akt/mTOR Pathway in Breast Cancer—A Preliminary Study
  Przemysław Kołodziej, Marcin Nicoś, Paweł A. Krawczyk, Jacek Bogucki, Agnieszka Karczmarczyk, Daniel Zalewski, Tomasz Kubrak, Elżbieta Kołodziej, Anna Makuch-Kocka, Barbara Madej-Czerwonka, Bartosz J. Płachno, Janusz Kocki, Anna Bogucka-Kocka
  International Journal of Molecular Sciences.2021; 22(4): 2061.     CrossRef
• Anticancer drug discovery from Iranian Chrysanthemum cultivars through system pharmacology exploration and experimental validation
  Mahboobeh Hodaei, Mehdi Rahimmalek, Mandana Behbahani
  Scientific Reports.2021;[Epub]     CrossRef
• Cell-free DNA comparative analysis of the genomic landscape of first-line hormone receptor-positive metastatic breast cancer from the US and China
  Xiaoran Liu, Andrew A. Davis, Feng Xie, Xinyu Gui, Yifei Chen, Qiang Zhang, Lorenzo Gerratana, Youbin Zhang, Ami N. Shah, Amir Behdad, Firas Wehbe, Yong Huang, Jianjun Yu, Pan Du, Shidong Jia, Huiping Li, Massimo Cristofanilli
  Breast Cancer Research and Treatment.2021; 190(2): 213.     CrossRef
• Network Pharmacology-Based Dissection of the Comprehensive Molecular Mechanisms of the Herbal Prescription FDY003 Against Estrogen Receptor-Positive Breast Cancer
  Ho-Sung Lee, In-Hee Lee, Kyungrae Kang, Sang-In Park, Minho Jung, Seung Gu Yang, Tae-Wook Kwon, Dae-Yeon Lee
  Natural Product Communications.2021;[Epub]     CrossRef
• Clinical significance of gene polymorphisms for hereditary predisposition to breast and ovarian cancer (review of literature)
  D. I. Vodolazhsky, A. V. Mayakovskaya, A. V. Kubyshkin, K. A. Aliev, I. I. Fomochkina
  Russian Clinical Laboratory Diagnostics.2021; 66(12): 760.     CrossRef
• Real world data analysis of next generation sequencing and protein expression in metastatic breast cancer patients
  Dirk Hempel, Florian Ebner, Arun Garg, Zeljka Trepotec, Armin Both, Werner Stein, Andreas Gaumann, Lucia Güttler, Wolfgang Janni, Amelie DeGregorio, Louisa Hempel, Valeria Milani
  Scientific Reports.2020;[Epub]     CrossRef
• PIK3CA H1047R Mutation Associated with a Lower Pathological Complete Response Rate in Triple-Negative Breast Cancer Patients Treated with Anthracycline-Taxane–Based Neoadjuvant Chemotherapy
  Sanxing Guo, Sibylle Loibl, Gunter von Minckwitz, Silvia Darb-Esfahani, Bianca Lederer, Carsten Denkert
  Cancer Research and Treatment.2020; 52(3): 689.     CrossRef
• Clinical-Pathologic Analysis of Breast Cancer With PIK3CA Mutations in Chinese Women
  Jing Lian, En-Wei Xu, Yan-Feng Xi, Hui-Wen Wang, Peng Bu, Jin-fen Wang, Li-Xia Wang
  Technology in Cancer Research & Treatment.2020;[Epub]     CrossRef
• PI3K/AKT/mTOR Signaling Pathway in Breast Cancer: From Molecular Landscape to Clinical Aspects
  Daniela Miricescu, Alexandra Totan, Iulia-Ioana Stanescu-Spinu, Silviu Constantin Badoiu, Constantin Stefani, Maria Greabu
  International Journal of Molecular Sciences.2020; 22(1): 173.     CrossRef
• Transcriptomic analysis associated with reversal of cisplatin sensitivity in drug resistant osteosarcoma cells after a drug holiday
  Divya Niveditha, Harshita Sharma, Syamantak Majumder, Sudeshna Mukherjee, Rajdeep Chowdhury, Shibasish Chowdhury
  BMC Cancer.2019;[Epub]     CrossRef
• PIK3CA Gene Mutations in Solid Malignancies: Association with Clinicopathological Parameters and Prognosis
  Ali Alqahtani, Hazem S. K. Ayesh, Hafez Halawani
  Cancers.2019; 12(1): 93.     CrossRef